Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000248980

Medchemexpress LLC Darovasertib (LXS196) | 1874276-76-2 | MFCD31544328 | >98% | 472.47 | C22H23F3N8O
SDP

Supplier:  Medchemexpress LLC HY10156925MG

Encompass_Preferred

Darovasertib (LXS196) is a potent, selective, orally active pan-protein kinase C (PKC) inhibitor developed for oncology research, with demonstrated low-nanomolar activity against multiple PKC isoforms. It is provided with characterization data and solubility guidance for preparation of experimental stocks, and is intended for research use in studies such as uveal melanoma models.

  • Potent inhibition of PKC isoforms at low nanomolar concentrations.
  • Selective, orally active small molecule suitable for in vitro and in vivo studies.
  • Characterized molecular formula and molecular weight for analytical confirmation.
  • Supplied with solubility and handling guidance for DMSO stock preparation.
  • High chemical purity appropriate for research applications.

Catalog No. 50-002-48980


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.